https://www.selleckchem.com/pr....oducts/17-AAG(Geldan
The present study comparatively analyzed short-term clinical effectiveness and long-term follow-up endpoints associated with robotic-assisted sphincter-preserving surgery (RAS) and laparoscopic-assisted sphincter-preserving surgery (LAS) when used to treat low rectal cancer. Within such a single-center retrospective cohort analysis, low rectal cancer patients that underwent RAS (n=20 or LAS (n=486) between January 2015 and beginning of July 2018 were enrolled. The mean operative durations in the RAS and LAS cohorts were 2
Like
Comment
Share
